AGN-242428

· AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGN-242428, covering 2021-04-06 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease [Phase 1, Phase 2]